PYC 7.50% $1.85 pyc therapeutics limited

Ann: First Competitive Read Out - Peptide Vaccine, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 10 Posts.
    lightbulb Created with Sketch. 5

    According to Telethon Kids' web site as of today, PYC is still listed as a researcher under contract.

    https://www.telethonkids.org.au/our-research/chronic-and-severe-diseases/cancer/drug-discovery-unit/

    The research of the unit is funded by contracts with several large pharmaceutical companies via a commercial entity named “Phylogica”, which was the first spin-off company from the Telethon Kids Institute. Listed on the Australian Stock Exchange, Phylogica (PYC) is a specialist drug discovery company that identifies new prototype drugs for pharmaceutical partners. In the last few years, Phylogica has entered into alliances with several of the leading global Pharmaceutical companies, including Roche, Pfizer, Medimmune (AstraZeneca), Janssen (Johnson and Johnson) and Genentech (a subsidiary of Roche).

 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
$1.85
Change
-0.150(7.50%)
Mkt cap ! $676.5M
Open High Low Value Volume
$2.00 $2.00 $1.82 $1.240M 660.9K

Buyers (Bids)

No. Vol. Price($)
1 2000 $1.82
 

Sellers (Offers)

Price($) Vol. No.
$1.85 6788 1
View Market Depth
Last trade - 16.10pm 28/11/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.